Insulet (PODD) Accumulated Depreciation & Amortization (2010 - 2025)
Insulet (PODD) reported Accumulated Depreciation & Amortization of $432.8 million for Q4 2025, up 19.43% on a YoY basis from $362.4 million in Q4 2024, and up 19.43% quarter-over-quarter from $362.4 million in Q4 2024.
Insulet (PODD) Accumulated Depreciation & Amortization (2010 - 2025) Analysis & Trends
Insulet has reported Accumulated Depreciation & Amortization for 16 years, with the latest figure at $432.8 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 19.43% year-over-year to $432.8 million; the trailing twelve-month figure through Dec 2025 stood at $432.8 million (up 19.43% YoY), and the FY2025 full-year result was $432.8 million, up 19.43% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 stood at $432.8 million, up from $362.4 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $432.8 million in Q4 2025, with the low at $57.4 million in Q4 2021.
- Historically, Accumulated Depreciation & Amortization has averaged $241.8 million across 5 years, with a median of $293.2 million in 2023.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation & Amortization rose 3.61% — and 2023, when it jumped 363.92%.
- Insulet's Accumulated Depreciation & Amortization stood at $57.4 million in 2021, then increased by 10.1% to $63.2 million in 2022, then jumped by 363.92% to $293.2 million in 2023, then gained by 23.6% to $362.4 million in 2024, then advanced by 19.43% to $432.8 million in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $432.8 million (Q4 2025), $362.4 million (Q4 2024), and $293.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Insulet | 10.47 Bn | 9.99 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 432.80 Mn |
| Dec 31, 2025 | 432.80 Mn |
| Dec 31, 2024 | 362.40 Mn |
| Dec 31, 2024 | 362.40 Mn |
| Dec 31, 2023 | 293.20 Mn |
| Dec 31, 2023 | 293.20 Mn |
| Dec 31, 2022 | 63.20 Mn |
| Dec 31, 2022 | 63.20 Mn |
| Dec 31, 2021 | 57.40 Mn |
| Dec 31, 2021 | 57.40 Mn |
| Dec 31, 2020 | 55.40 Mn |
| Dec 31, 2020 | 55.40 Mn |
| Dec 31, 2019 | 27.90 Mn |
| Dec 31, 2019 | 27.90 Mn |
| Dec 31, 2018 | 15.60 Mn |
| Dec 31, 2018 | 15.60 Mn |
| Dec 31, 2017 | 13.90 Mn |
| Dec 31, 2017 | 13.90 Mn |
| Dec 31, 2016 | 13.83 Mn |
| Dec 31, 2016 | 13.83 Mn |